BMS 180742

• Description:

  BMS 180742 is a thrombin exosite inhibitor. BMS 180742 does not inhibit arterial thrombosis[1].

• UNSPSC:

  12352209

• Target:

  Thrombin

• Type:

  Peptides

• Related Pathways:

  Metabolic Enzyme/Protease

• Applications:

  Neuroscience-Neuromodulation

• Field of Research:

  Cardiovascular Disease

• Assay Protocol:

  https://www.medchemexpress.com/bms-180742.html

• Smiles:

  O=C([C@H]1N(CCC1)C([C@H](CCC(O)=O)NC([C@@H](NC(CCC(O)=O)=O)CC2=CC=CC=C2)=O)=O)N[C@@H]([C@@H](C)CC)C(N3[C@@H](CCC3)C(N[C@@H](CCC(O)=O)C(N[C@@H](CCC(O)=O)C(N[C@H](C(N[C@H](C(N[C@H](C(O)=O)CCC(N)=O)=O)CC4CCCCC4)=O)CC5=CC=C(C=C5)O)=O)=O)=O)=O

• Molecular Formula:

  C67H93N11O22

• Molecular Weight:

  1404.52

• References & Citations:

  [1]Schumacher WA, et al. Comparison of thrombin active site and exosite inhibitors and heparin in experimental models of arterial and venous thrombosis and bleeding. J Pharmacol Exp Ther. 1993 Dec;267 (3) :1237-42.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Peptides

• Clinical Information:

  No Development Reported

• CAS Number:

  [138828-04-3]